Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Amgen Stock Dives
Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.
Amgen stock was dropping sharply Tuesday after releasing what looked like positive data from a Phase 2 study for its experimental monthly weight-loss shot MariTide.Overweight or obese patients on MariTide lost 20% of their body weight on average,
Amgen's weight-loss drug fails to impress in study; shares plunge
Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 people who were overweight or obese, the company said on Tuesday.
New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.
1d
Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed
Amgen (AMGN) reported today the highly anticipated results of a mid-stage trial of its experimental weight loss drug and ...
2d
AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY
Amgen (NASDAQ:AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide ...
21h
Amgen price target lowered to $330 from $360 at RBC Capital
RBC Capital analyst Gregory Renza lowered the firm’s price target on Amgen (AMGN) to $330 from $360 and keeps an Outperform rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
China releases 3 Americans
Wins reelection after recount
Concedes in CA House race
Cybertruck crash kills 3
Stowaway found on flight
Residents sue Givaudan
Meets Trump at Mar-a-Lago
NM man awarded $412M+
Jan. 6 coverage suit tossed
Retires after 14 seasons
Migration talk with MX pres
Habitat protections plan
Settles harassment lawsuit
Bail denied by third judge
Court upholds TX razor wire
Costco recalls eggs
Thanksgiving in space
Uber faces FTC probe
Travel advisory downgraded
Capitol Hill visit on Dec 5
Abortions fell 2% in 2022
Menendez seeks new trial
Picked as envoy for UKR, RU
Weekly jobless claims fall
US economy expanded
'City under the ice'
Recalling over 226K vehicles
US sanctions more allies
To restrict filters for teens
Man freed, gets $13M award
Feedback